H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Neutral rating on Leap Therapeutics (NASDAQ: LPTX).The analyst commented: "On March 26, Leap ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE